Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMDNASDAQ:NEPHOTCMKTS:UEECOTCMKTS:YBGJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.76-10.7%$2.92$1.75▼$8.44$3.54M1.89215,482 shs66,122 shsNEPHNephros$3.87-3.5%$2.38$1.36▼$4.26$41.02M0.9614,434 shs59,165 shsUEECUnited Health Products$0.13+8.3%$0.22$0.05▼$0.28$33.30M-1.36130,001 shs86,583 shsYBGJYubo International Biotech$0.08+17.8%$0.07$0.03▼$1.37$9.06M3.9523,173 shs40,000 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical-2.48%-27.04%-40.55%-34.09%-52.88%NEPHNephros+5.53%+17.94%+84.79%+152.20%+84.79%UEECUnited Health Products+8.33%+4.00%-45.81%-27.78%-19.25%YBGJYubo International Biotech+17.76%-24.40%-15.06%+11.34%-92.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical3.1101 of 5 stars3.55.00.00.02.50.01.3NEPHNephros1.8683 of 5 stars3.53.00.00.01.90.80.0UEECUnited Health Products0.5641 of 5 stars0.05.00.00.02.00.00.0YBGJYubo International BiotechN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 3.00Buy$56.003,081.82% UpsideNEPHNephros 3.00Buy$5.0029.20% UpsideUEECUnited Health Products 0.00N/AN/AN/AYBGJYubo International Biotech 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K6.21N/AN/A$2.19 per share0.80NEPHNephros$15.52M2.64N/AN/A$0.80 per share4.84UEECUnited Health Products$40K832.51N/AN/A($0.01) per share-13.00YBGJYubo International Biotech$610K14.85N/AN/A($0.02) per share-3.78Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$12.21M-$12.64N/AN/AN/AN/A-153.96%-109.13%6/26/2025 (Estimated)NEPHNephros-$1.58M$0.07N/A∞N/A-6.86%-11.39%-8.30%8/6/2025 (Estimated)UEECUnited Health Products-$2.62M-$0.02N/A∞N/AN/AN/A-840.17%N/AYBGJYubo International Biotech-$1.20M-$0.01N/A∞N/AN/AN/A-121.41%N/ALatest YBGJ, NEPH, UEEC, and AEMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/26/2025Q4 2025AEMDAethlon Medical-$0.13N/AN/AN/AN/AN/A5/15/2025Q1 2025NEPHNephros-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 million3/28/2025Q4 2024UEECUnited Health ProductsN/A-$0.01N/A-$0.01N/AN/A3/24/2025Q4 2024NEPHNephros-$0.01$0.03+$0.04$0.03$3.67 million$3.87 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/ANEPHNephrosN/AN/AN/AN/AN/AUEECUnited Health ProductsN/AN/AN/AN/AN/AYBGJYubo International BiotechN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A2.802.80NEPHNephrosN/A6.954.02UEECUnited Health ProductsN/A0.030.03YBGJYubo International BiotechN/A0.160.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%NEPHNephros41.10%UEECUnited Health Products0.07%YBGJYubo International BiotechN/AInsider OwnershipCompanyInsider OwnershipAEMDAethlon Medical1.20%NEPHNephros6.70%UEECUnited Health Products1.50%YBGJYubo International Biotech68.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.01 million14.30 millionNo DataNEPHNephros3010.60 million10.11 millionNot OptionableUEECUnited Health Products4256.16 million246.33 millionNot OptionableYBGJYubo International Biotech20119.82 million52.15 millionNot OptionableYBGJ, NEPH, UEEC, and AEMD HeadlinesRecent News About These CompaniesYubo International Biotech Limited (YBGJ)March 21, 2025 | finance.yahoo.comYubo International Biotech LimitedNovember 21, 2024 | investing.comYBGJ Yubo International Biotech LimitedMay 25, 2024 | seekingalpha.comForever Cheer picks Hong Kong as gateway for global launch of pain management drugs with an eye on US$88.2 billion marketJanuary 3, 2024 | scmp.comPromontory Therapeutics Selected as the First International Biotech Company Member of the Paris-Saclay Cancer ClusterOctober 1, 2023 | finance.yahoo.comSABAH OFFERS TREASURE TROVE OF GENETIC RESOURCES FOR BIOTECH - MINISTERSeptember 10, 2023 | bernama.comAs biotech conference arrives in Boston, Wu launches push to diversify industryJuly 6, 2023 | wgbh.orgYubo International Biotech Ltd.June 15, 2023 | wsj.comChemical Engineering (Biotechnology) MEApril 20, 2023 | buffalo.eduBiotechnology – A Solution to Hunger?February 12, 2023 | un.orgCovid-19: Bharat Biotech to launch intranasal vaccine on January 26January 23, 2023 | scroll.inGLOBAL TOTAL REWARDS AND INTERNATIONAL MOBILITY HEADDecember 25, 2022 | mypharma-editions.comBiology newsSeptember 14, 2022 | phys.orgBiotechnology Act to Crash Cost of Vaccines, Drugs Import, Drive ResearchSeptember 12, 2022 | thisdaylive.comYubo International (OTC:YBGJ), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comYubo International (OTC:YBGJ), Analyst Ratings, Price Targets, PredictionsJuly 18, 2022 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeYBGJ, NEPH, UEEC, and AEMD Company DescriptionsAethlon Medical NASDAQ:AEMD$1.76 -0.21 (-10.66%) Closing price 04:00 PM EasternExtended Trading$1.80 +0.03 (+1.99%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Nephros NASDAQ:NEPH$3.87 -0.14 (-3.49%) Closing price 04:00 PM EasternExtended Trading$3.86 0.00 (-0.13%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.United Health Products OTCMKTS:UEEC$0.13 +0.01 (+8.33%) As of 06/12/2025 03:28 PM EasternUnited Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.Yubo International Biotech OTCMKTS:YBGJ$0.08 +0.01 (+17.76%) As of 06/12/2025 03:32 PM EasternYubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
